Cargando…

Nutrition in Cystic Fibrosis: as important as the management of pulmonary disease

Detalles Bibliográficos
Autor principal:	Adde, Fabíola Villac
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade de Pediatria de São Paulo 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436949/ https://www.ncbi.nlm.nih.gov/pubmed/25623727 http://dx.doi.org/10.1016/j.rpped.2014.12.001

Ejemplares similares

Shwachman-Kulczycki score still useful to monitor cystic fibrosis severity
por: Stollar, Fabíola, et al.
Publicado: (2011)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Effectiveness of a multistep Pseudomonas aeruginosa eradication treatment protocol in children with cystic fibrosis in Brazil
por: Riquena, Barbara, et al.
Publicado: (2020)

Two Steps Forward: Improving the Management of Cystic Fibrosis Pulmonary Exacerbations
por: Waters, Valerie
Publicado: (2021)

Brazilian guidelines for the diagnosis and treatment of cystic fibrosis
por: Athanazio, Rodrigo Abensur, et al.
Publicado: (2017)

Quality of life amongst adolescents and young adults with cystic fibrosis: correlations with clinical outcomes
por: Gancz, Daniela W, et al.
Publicado: (2018)

Zinc Nutritional Status in Patients with Cystic Fibrosis
por: Escobedo Monge, Marlene Fabiola, et al.
Publicado: (2019)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Cystic fibrosis revisited
por: Kulkarni, H, et al.
Publicado: (2019)

Early Antibiotics in Cystic Fibrosis: Lessons from the Cystic Fibrosis Pig Model
por: Lu, Shiping, et al.
Publicado: (2021)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

Understanding Cystic Fibrosis Comorbidities and Their Impact on Nutritional Management
por: Patel, Dhiren, et al.
Publicado: (2022)

The Microbiome in Cystic Fibrosis Pulmonary Disease
por: Françoise, Alice, et al.
Publicado: (2020)

When is cystic fibrosis not cystic fibrosis? The importance of appropriately classifying patients
por: Faro, Albert, et al.
Publicado: (2022)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis: “Ionocyte Modulators”?
por: Shah, Viral S., et al.
Publicado: (2023)

The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
por: Maetz, Jessica, et al.
Publicado: (2021)

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?
por: Caverly, Lindsay J.
Publicado: (2022)

Follow-up on pediatric patients with bronchiolitis obliterans treated with corticosteroid pulse therapy
por: Tomikawa, Silvia Onoda, et al.
Publicado: (2014)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Cystic fibrosis in Brazil: achievements in survival
por: Vendrusculo, Fernanda Maria, et al.
Publicado: (2021)

The Impact of COVID-19 in Cystic Fibrosis
por: Flume, Patrick A., et al.
Publicado: (2022)

Evidence for Early Cystic Fibrosis Transmembrane Conductance Regulator Modulator Treatment for Children with Cystic Fibrosis Keeps Growing
por: Hoppe, Jordana E., et al.
Publicado: (2022)

Brazilian Guidelines for Nutrition in Cystic Fibrosis
por: Neri, Lenycia de Cassya Lopes, et al.
Publicado: (2022)

Nutritional Care in Children with Cystic Fibrosis
por: Mariotti Zani, Elena, et al.
Publicado: (2023)

Evolving Nutritional Needs in Cystic Fibrosis
por: Frantzen, Theresa, et al.
Publicado: (2023)

Scoring tools to monitor risk of disease progression in patients with cystic fibrosis
por: Donadio, Márcio Vinícius Fagundes, et al.
Publicado: (2020)

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome
por: Cantin, André M.
Publicado: (2019)

CFTR Modulators to the Rescue of Individuals with Cystic Fibrosis and Advanced Lung Disease
por: Myerburg, Mike, et al.
Publicado: (2021)

Cystic Fibrosis: A Disease in Transformation, yet More Work to Be Done!
por: Ramsey, Bonnie W., et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis management: caring is sparing
por: Nava, Stefano, et al.
Publicado: (2020)

New Developments in Cystic Fibrosis Airway Inflammation
por: Palaniyar, Nades, et al.
Publicado: (2015)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Recent advances in the understanding and management of cystic fibrosis pulmonary exacerbations
por: Skolnik, Kate, et al.
Publicado: (2018)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Steps toward Cell Therapy for Cystic Fibrosis
por: Koh, Kyung Duk, et al.
Publicado: (2020)

Cystic fibrosis-related diabetes: The unmet need
por: Pozo, Leonardo, et al.
Publicado: (2020)

Preclinical Modeling for Therapeutic Development in Cystic Fibrosis
por: Bonfield, Tracey L.
Publicado: (2020)

Cystic Fibrosis Inflammation: Hyperinflammatory, Hypoinflammatory, or Both?
por: Murphy, Sean V., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3sbav96fe87m30meq1mb4k8t1l